Cargando…
Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
We recently demonstrated that statins mediate protection against intracellular pathogens, Mycobacterium tuberculosis and Listeria monocytogenes in mice. Here, we investigated the immunomodulatory potential of simvastatin as a topical or systemic host-directed drug therapy in controlling inflammatory...
Autores principales: | Parihar, Suraj P., Hartley, Mary-Anne, Hurdayal, Ramona, Guler, Reto, Brombacher, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025842/ https://www.ncbi.nlm.nih.gov/pubmed/27632901 http://dx.doi.org/10.1038/srep33458 |
Ejemplares similares
-
Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis
por: Hurdayal, Ramona, et al.
Publicado: (2017) -
Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape
por: Parihar, Suraj P., et al.
Publicado: (2013) -
Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis
por: Govender, Melissa, et al.
Publicado: (2018) -
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
por: Guler, Reto, et al.
Publicado: (2021) -
Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?
por: Aruleba, Raphael Taiwo, et al.
Publicado: (2020)